Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors

    NEXT STORY
    Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020
    PREV STORY
    Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunovaccine to Present at 19th Annual Rodman & Renshaw Global Investment Conference

    HALIFAX, Nova Scotia, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

    author_avatar
    NASDAQ Market News

    Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

    REDWOOD CITY, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: FIT BIOTECH OY FINANCIAL STATEMENT BULLETIN JANUARY 1 – DECEMBER 31, 2017

    FIT Biotech Oy: FIT BIOTECH OY FINANCIAL STATEMENT BULLETIN JANUARY 1 - DECEMBER 31, ...

    author_avatar
    NASDAQ Market News